Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 720 Neoplasms 458 Prostatic Neoplasms 397 Carcinoma, Non-Small-Cell Lung 387 Lung Neoplasms 308 Leukemia, Myeloid, Acute 300 Multiple Myeloma 269 Colorectal Neoplasms 242 Neoplasm Metastasis 240 Pancreatic Neoplasms 236 Leukemia 235 Melanoma 214 Lymphoma 213 Precursor Cell Lymphoblastic Leukemia-Lymphoma 204 Brain Neoplasms 193 Recurrence 178 Head and Neck Neoplasms 177 Lymphoma, Non-Hodgkin 173 Leukemia, Lymphocytic, Chronic, B-Cell 168 Myelodysplastic Syndromes 166 Ovarian Neoplasms 160 Carcinoma, Hepatocellular 154 Glioblastoma 149 Carcinoma, Renal Cell 137 Rectal Neoplasms 134 Colonic Neoplasms 129 Lymphoma, Large B-Cell, Diffuse 125 Lymphoma, Follicular 125 Hodgkin Disease 115 Squamous Cell Carcinoma of Head and Neck 109

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × Tetanus × Clear all

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡